Literature DB >> 26341467

Onco-nephrology: a decalogue.

Laura Cosmai1, Camillo Porta2, Maurizio Gallieni3, Mark A Perazella4.   

Abstract

Onco-nephrology is an evolving subspecialty that focuses on the complex relationships existing between kidney and cancer. In this opinion piece, we propose a 'decalogue of onco-nephrology', in order to highlight the areas where the nephrologist and oncologist should work closely over the ensuing years to provide cutting-edge care for patients afflicted with cancer and kidney disease. The 10 points we have highlighted include (1) acute kidney injury and chronic kidney disease in cancer patients; (2) nephrotoxic effects of anticancer therapy, either traditional chemotherapeutics or novel molecularly targeted agents; (3) paraneoplastic renal manifestations; (4) management of patients nephrectomized for a kidney cancer; (5) renal replacement therapy and active oncological treatments; (6) kidney transplantation in cancer survivors and cancer risk in ESRD patients; (7) oncological treatment in kidney transplant patients; (8) pain management in patients with cancer and kidney disease, (9) development of integrated guidelines for onco-nephrology patients and (10) clinical trials designed specifically for onco-nephrology. Following these points, a multidisciplinary onco-nephrology team will be key to providing outstanding, cutting-edge care in both the acute and chronic setting to these patients.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  AKI; CKD; cancer; dialysis; nephrectomy; nephrotoxicity

Mesh:

Substances:

Year:  2015        PMID: 26341467     DOI: 10.1093/ndt/gfv320

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.

Authors:  Ryutaro Ishitsuka; Jun Miyazaki; Daishi Ichioka; Takamitsu Inoue; Susumu Kageyama; Mikio Sugimoto; Koji Mitsuzuka; Yoshiyuki Matsui; Yusuke Shiraishi; Hidefumi Kinoshita; Hironobu Wakeda; Takeshi Nomoto; Eiji Kikuchi; Koji Kawai; Hiroyuki Nishiyama
Journal:  Clin Exp Nephrol       Date:  2016-08-26       Impact factor: 2.801

Review 2.  Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).

Authors:  Laura Cosmai; Maurizio Gallieni; Wanda Liguigli; Camillo Porta
Journal:  J Nephrol       Date:  2016-05-06       Impact factor: 3.902

Review 3.  Acute kidney injury in cancer patients.

Authors:  Shuiying Liu; Jinyuan Zhao; Feng Wang
Journal:  Clin Exp Nephrol       Date:  2021-09-09       Impact factor: 2.801

4.  Trends and Outcomes with Kidney Failure from Antineoplastic Treatments and Urinary Tract Cancer in France.

Authors:  Imène Mansouri; Natalia Alencar de Pinho; Renaud Snanoudj; Christian Jacquelinet; Mathilde Lassalle; Clémence Béchade; Cécile Vigneau; Florent de Vathaire; Nadia Haddy; Bénédicte Stengel
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-06       Impact factor: 8.237

Review 5.  Acute kidney injury in critically ill cancer patients: an update.

Authors:  Norbert Lameire; Raymond Vanholder; Wim Van Biesen; Dominique Benoit
Journal:  Crit Care       Date:  2016-08-02       Impact factor: 9.097

6.  Acute kidney injury in critically ill cancer patients is associated with mortality: A retrospective analysis.

Authors:  Nina Seylanova; Siobhan Crichton; Jing Zhang; Richard Fisher; Marlies Ostermann
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 7.  Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications.

Authors:  Alessandra Cuomo; Flora Pirozzi; Umberto Attanasio; Riccardo Franco; Francesco Elia; Eliana De Rosa; Michele Russo; Alessandra Ghigo; Pietro Ameri; Carlo Gabriele Tocchetti; Valentina Mercurio
Journal:  Curr Oncol Rep       Date:  2020-12-02       Impact factor: 5.075

Review 8.  Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies.

Authors:  Laura Cosmai; Camillo Porta; Carmelo Privitera; Loreto Gesualdo; Giuseppe Procopio; Stefania Gori; Andrea Laghi
Journal:  ESMO Open       Date:  2020-03

9.  Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis.

Authors:  Chaan S Ng; Sanjeeva P Kalva; Candace Gunnarsson; Michael P Ryan; Erin R Baker; Ravindra L Mehta
Journal:  Cancer Imaging       Date:  2018-08-24       Impact factor: 3.909

Review 10.  New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management.

Authors:  Alessandra Cuomo; Francesca Paudice; Giovanni D'Angelo; Giovanni Perrotta; Antonio Carannante; Umberto Attanasio; Martina Iengo; Francesco Fiore; Carlo Gabriele Tocchetti; Valentina Mercurio; Flora Pirozzi
Journal:  Curr Heart Fail Rep       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.